Type: rating_drop

Analysts KeyBanc downgraded Nike (NKE) to sector weight due to insufficient progress in turnaround efforts

06/26/2026, 04:37 AM investing rating_drop Analysts: analysts, KeyBanc retail

KeyBanc has downgraded Nike's stock to sector weight, indicating that the company's efforts to revitalize its brand have not progressed sufficiently to warrant a buy recommendation. This downgrade reflects broader concerns about Nike's performance in key markets, particularly China and Europe.

Analysts Jefferies lowered Rheinmetall (RHM) price target by 31% to €1,300 following Germany’s cancellation of the F126 naval program

06/25/2026, 02:36 AM rating_drop Analysts: analysts, Jefferies defense

The cancellation of Germany's F126 naval program has led to a decline in European defense stocks, highlighting the volatility of government procurement in the defense sector and raising concerns about future spending commitments.

Analysts Bank of America downgraded Principal Financial Group (PFG) to underperform amid expectations of slowing income growth

06/24/2026, 10:37 AM rating_drop Analysts: analysts, Bank of America finance

Midday trading saw significant movements in various sectors, with notable declines for Principal Financial Group and Cerebras, while travel stocks and KB Home experienced substantial gains, reflecting shifting investor sentiment and sector performance.

Analysts Wolfe Research downgraded Home Depot (HD) to Hold amid housing market concerns

06/23/2026, 09:39 AM business rating_drop Analysts: analysts, Wolfe Research retail

The CNBC Investing Club highlighted recent market movements and stock downgrades, emphasizing the potential for strategic buying opportunities amid volatility, particularly in the technology and retail sectors.

Analysts Evercore ISI downgraded Nike (NKE) to in-line and lowered price target to $46, citing limited upside

06/23/2026, 05:38 AM investing rating_drop Analysts: analysts, Evercore ISI

Nike's efforts to improve its share price through a turnaround strategy face significant challenges, leading Evercore ISI to downgrade the stock and lower its price target, indicating limited near-term upside for investors.

Analysts KeyBanc initiates coverage on SpaceX (SPCX) with Sector Weight rating, citing high valuation risks

06/22/2026, 07:38 AM investing rating_drop Analysts: analysts, KeyBanc, KeyBanc Capital Markets aero_defense

KeyBanc Capital Markets has initiated coverage of SpaceX with a Sector Weight rating, indicating that the stock's current valuation may already reflect its long-term growth potential, suggesting limited upside for investors.

Analysts UBS lowered Zealand Pharma (ZEAL) price target to 540 Danish kroner amid concerns over survodutide’s tolerability

06/18/2026, 10:36 PM business rating_drop Analysts: analysts, UBS biotech

Zealand Pharma's stock has faced significant declines following disappointing data on its weight loss drug survodutide, leading analysts to reduce sales forecasts and shift focus to its other drug, petrelintide, which may offer better prospects in the obesity market.

BMW (BMW.DE) Shares Hit 5-Year Low Following Profit Warning Amid China Slowdown and Iran War

06/17/2026, 05:36 AM rating_drop Analysts: analysts, Citi auto

BMW's shares fell to a five-year low after the company lowered its profit outlook for 2026, primarily due to declining demand in China and rising costs linked to the Iran war, raising concerns about the broader European auto sector.

Analysts CFRA initiate coverage of SpaceX (SPACE) with a sell rating and a 12-month price target of $115, citing elevated valuation concerns

06/15/2026, 01:37 AM economy rating_drop Analysts: analysts, CFRA ai

SpaceX's shares surged in premarket trading following a historic IPO, raising questions about the sustainability of its high valuation amidst significant losses and varying analyst opinions.

Analysts CFRA assigned a sell rating to SpaceX (SPCX) with a 12-month price target of $115, citing elevated valuation expectations

06/12/2026, 10:37 AM investing rating_drop Analysts: analysts, CFRA ai

CFRA has issued a sell rating for SpaceX shortly after its Nasdaq debut, setting a 12-month price target significantly below its initial offering price, highlighting concerns over the company's high valuation and reliance on the success of its Starship rocket.